• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中波紫外线防晒剂对5-甲氧基补骨脂素光致肿瘤发生的影响:无毛白化小鼠的统计学和组织学研究

Modification of 5-methoxypsoralen phototumorigenesis by UVB sunscreens: a statistical and histologic study in the hairless albino mouse.

作者信息

Young A R, Gibbs N K, Magnus I A

机构信息

Department of Photobiology, United Medical School of Guy's, London.

出版信息

J Invest Dermatol. 1987 Dec;89(6):611-7. doi: 10.1111/1523-1747.ep12461386.

DOI:10.1111/1523-1747.ep12461386
PMID:3680986
Abstract

Sunscreen preparations containing 5-methoxypsoralen at 25 micrograms/ml and 50 micrograms/ml, and the appropriate vehicle only, sunscreen only, and 5-methoxypsoralen only controls, were assessed for tumorigenic potential in hairless albino mice exposed to solar simulated radiation for a period of 44-46 weeks. Some animals were observed for a 15 week post-irradiation period. A wide range of statistical analyses has shown that, during the course of irradiation, the inclusion of sunscreens eliminates the enhancement of phototumorigenesis and malignancy that is normally observed with 5-methoxypsoralen. There was, however, some indication of increased risk at the end of the postirradiation follow-up period. Possible reasons for the protective effect of the sunscreens and the relevance of these data to the assessment of human risk are discussed.

摘要

对含有浓度为25微克/毫升和50微克/毫升的5-甲氧基补骨脂素的防晒制剂、仅含相应赋形剂的对照组、仅含防晒剂的对照组以及仅含5-甲氧基补骨脂素的对照组,在暴露于模拟太阳辐射44 - 46周的无毛白化小鼠中评估其致瘤潜力。部分动物在照射后观察15周。大量统计分析表明,在照射过程中,添加防晒剂可消除通常在使用5-甲氧基补骨脂素时观察到的光致瘤作用和恶性程度增强。然而,在照射后随访期结束时有一些风险增加的迹象。讨论了防晒剂产生保护作用的可能原因以及这些数据与人类风险评估的相关性。

相似文献

1
Modification of 5-methoxypsoralen phototumorigenesis by UVB sunscreens: a statistical and histologic study in the hairless albino mouse.中波紫外线防晒剂对5-甲氧基补骨脂素光致肿瘤发生的影响:无毛白化小鼠的统计学和组织学研究
J Invest Dermatol. 1987 Dec;89(6):611-7. doi: 10.1111/1523-1747.ep12461386.
2
Phototumorigenesis studies of 5-methoxypsoralen in bergamot oil: evaluation and modification of risk of human use in an albino mouse skin model.佛手柑油中5-甲氧基补骨脂素的光致肿瘤发生研究:在白化病小鼠皮肤模型中评估和修正人类使用风险
J Photochem Photobiol B. 1990 Nov;7(2-4):231-50. doi: 10.1016/1011-1344(90)85159-t.
3
Effect on topical 5-methoxypsoralen on tumorigenesis induced in albino and pigmented hairless mouse skin by UV irradiation.局部应用5-甲氧基补骨脂素对紫外线照射诱导的白化和无毛有色小鼠皮肤肿瘤发生的影响。
J Photochem Photobiol B. 1990 May;5(3-4):343-57. doi: 10.1016/1011-1344(90)85050-7.
4
Is psoralen-containing sunscreen tumorigenic in hairless mice?
J Am Acad Dermatol. 1984 Feb;10(2 Pt 1):293-4. doi: 10.1016/s0190-9622(84)80226-1.
5
A comparison of the phototumorigenic potential of 8-MOP and 5-MOP in hairless albino mice exposed to solar simulated radiation.对无毛白化小鼠暴露于模拟太阳辐射下8-甲氧基补骨脂素和5-甲氧基补骨脂素的光致瘤潜力的比较。
Br J Dermatol. 1983 May;108(5):507-18. doi: 10.1111/j.1365-2133.1983.tb01050.x.
6
Psoralen-containing sunscreen is tumorigenic in hairless mice.含补骨脂素的防晒霜对无毛小鼠具有致瘤性。
J Am Acad Dermatol. 1983 Jun;8(6):830-6. doi: 10.1016/s0190-9622(83)80012-7.
7
Psoralen-containing sunscreen induces phototoxicity and epidermal ornithine decarboxylase activity.含补骨脂素的防晒霜会诱发光毒性和表皮鸟氨酸脱羧酶活性。
J Am Acad Dermatol. 1982 Jun;6(6):1022-7. doi: 10.1016/s0190-9622(82)70086-6.
8
Failure of UVR dose reciprocity for skin tumorigenesis in hairless mice treated with 8-methoxypsoralen.
Photochem Photobiol. 1985 Jul;42(1):39-42. doi: 10.1111/j.1751-1097.1985.tb03545.x.
9
A first approach to an action spectrum for 8-MOP phototumorigenesis in mice.
J Invest Dermatol. 1988 Feb;90(2):175-8. doi: 10.1111/1523-1747.ep12462176.
10
Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice.防晒霜对紫外线辐射诱导的小鼠黑色素瘤生长增强的影响。
J Natl Cancer Inst. 1994 Jan 19;86(2):99-105. doi: 10.1093/jnci/86.2.99.